News

Stocktwits on MSN8d
Johnson & Johnson’s Psoriasis Drug Meets Goal In Late Stage Study: Retail Yet To Be Impressed
Shares of Johnson & Johnson (JNJ) were in the spotlight on Friday morning after the company announced positive results from ...
Pharm Exec1mon
Johnson & Johnson’s Icotrokinra Demonstrates Significant Skin Clearance in Adolescents with Moderate-to-Severe Plaque Psoriasis
The current estimated prevalence of psoriasis is 1.5% in African Americans and 3.6% in Caucasians. 3 “Adolescents living with moderate to severe plaque psoriasis shouldn’t have to wait for effective ...